Journal of Biomedical Physics and Engineering

Radiation Induced Demyelination in Cervical Spinal Cord of the Head and Neck Cancer Patients after Receiving Radiotherapy

Document Type : Original Research

Authors

H Goyal 1
N Singh 2
O P Gurjar 3
R K Tanwar 1

1 MD, Department of Radiotherapy, Government Medical College & Hospital, Kota, India

2 PhD, Department of Radiotherapy, King George Medical University, Lucknow, India

3 PhD, Government Cancer Hospital, Mahatma Gandhi Memorial Medical College, Indore, India

https://doi.org/10.31661/jbpe.v0i0.1055
Abstract
Background: Cervical spinal cord is important and radiosensitive. It is the most critical organ for the head and neck (H&N) cancer patients during radiotherapy. If the delivered dose to the cord is more than tolerance dose, demyelination may occur.
Objective: Current study aims to analyze the post radiotherapy status of cord in the H&N cancer patients.
Material and Methods: In this analytical study, sixty patients who received more than 50 Gray (Gy) dose for more than 10 cm length of spinal cord participated in the study. All the patients were clinically examined and magnetic resonance imaging (MRI) was performed for patients who had demyelination symptoms. Adequate medical management was provided for all the patients having demyelination.
Results: Out of sixty patients, ten cases were reported with demyelination symptoms, and only six cases gave consent for this study. One patient was found to have irreversible demyelination while five patients had reversible demyelination.
Conclusion: Demyelination may occur if long segment spinal cord receives dose more than tolerance limit. However target dose should not be compromised up to 54 Gy to spinal cord.

Keywords

Spinal Cord
Demyelination
Myelin
Radiotherapy
Magnetic Resonance Imaging
  1. Boullerne AI. The history of myelin. Exp Neurol. 2016;283:431-45.
  2. Weil MT, Mobius W, Winkler A, Ruhwedel T, Wrzos C, Romanelli E, et al. Loss of Myelin Basic Protein Function Triggers Myelin Breakdown in Models of Demyelinating Diseases. Cell Rep. 2016;16:314-22. doi: 10.1016/j.celrep.2016.06.008. PubMed PMID: 27346352.PubMed PMCID: PMC4949381.
  3. Konopaske GT, Dorph-Petersen KA, Sweet RA, Pierri JN, Zhang W, Sampson AR, et al. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry. 2008;63:759-65. doi: 10.1016/j.biopsych.2007.08.018. PubMed PMID: 17945195. PubMed PMCID: PMC2386415.
  4. Love S. Demyelinating diseases. J Clin Pathol. 2006;59:1151-9. doi: 10.1136/jcp.2005.031195. PubMed PMID: 17071802. PubMed PMCID: PMC1860500.
  5. Okada S, Okeda R. Pathology of radiation myelopathy. Neuropathology. 2001;21:247-65. doi: 10.1046/j.1440-1789.2001.00408.x. PubMed PMID: 11837531.
  6. Ahlbom HE. The results of radiotherapy of hypopharyngeal cancer at the Radiumhemmet, Stockholm, 1930 to 1939. Acta Radiol. 1941;22:155-71. doi: 10.3109/00016924109171582.
  7. Jellinger K, Sturm KW. Delayed radiation myelopathy in man. Report of twelve necropsy cases. J Neurol Sci. 1971;14:389-408. PubMed PMID: 5125754. doi: 10.1016/0022-510x(71)90174-2.
  8. Kristensson K, Molin B, Sourander P. Delayed radiation lesions of the human spinal cord. Report of five cases. Acta Neuropathol. 1967;9:34-44. doi: 10.1007/bf00688156. PubMed PMID: 6049792.
  9. Palmer JJ. Radiation myelopathy. Brain. 1972;95:109-22. doi: 10.1093/brain/95.1.109. PubMed PMID: 5023080.
  10. Reagan TJ, Thomas JE, Colby MY. Chronic progressive radiation myelopathy. Its clinical aspects and differential diagnosis. JAMA. 1968;203:106-10. doi: 10.1001/jama.1968.03140020034009.PubMed PMID: 5694057.
  11. Burger PC, Mahley Jr MS, Dudka L, Vogel FS. The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer. 1979;44:1256-72. doi: 10.1002/1097-0142(197910)44:43.0.co;2-t. PubMed PMID: 387205.
  12. Leibel S, Sheline G. Tolerance of the brain and spinal cord to conventional irradiation. United States: Radiation injury to the nervous system; 1991. p. 211-238.
  13. Schultheiss TE, Kun LE, Ang KK, Stephens LC. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys. 1995;31:1093-112. doi: 10.1016/0360-3016(94)00655-5. PubMed PMID: 7677836.
  14. Lengyel Z, Reko G, Majtenyi K, Pisch J, Csornai M, Lesznyak J, et al. Autopsy verifies demyelination and lack of vascular damage in partially reversible radiation myelopathy. Spinal Cord. 2003;41:577-85. doi: 10.1038/sj.sc.3101480. PubMed PMID: 14504618.
  15. Tillema JM, Pirko I. Neuroradiological evaluation of demyelinating disease. Ther Adv Neurol Disord. 2013;6:249-68. doi: 10.1177/1756285613478870. PubMed PMID: 23858328. PubMed PMCID: PMC3707351.
  16. Symptoms of Multiple Sclerosis and Myelin Sheath Degeneration [Internet]. c2004-2017. [Accessed 28 October 2017]. Available from: https://evenbetterhealth.com.
Journal of Biomedical Physics and Engineering
Volume 10, Issue 1
37
February 2020
Pages 1-6

Home

Guide for Authors

Submit Manuscript

Guide for Reviewers

Contact Us